Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Akero Therapeutics (AKRO) shares
Learn how to easily invest in Akero Therapeutics shares.
Akero Therapeutics is a biotechnology business based in the US. Akero Therapeutics stocks (AKRO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $25.36 – a decrease of 7.49% over the previous week. Akero Therapeutics employs 31 staff and has a market cap (total outstanding stock value) of $776.6 million.
How to buy shares in Akero Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AKRO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Akero Therapeutics?
- Has coronavirus impacted Akero Therapeutics shares?
- Akero Therapeutics shares summary
- Compare share dealing platforms
- Is Akero Therapeutics stock a buy or sell?
- Akero Therapeutics performance over time
- Akero Therapeutics's financials
- How volatile are Akero Therapeutics shares?
- Does Akero Therapeutics pay a dividend?
- Other common questions
Akero Therapeutics stock price (NASDAQ:AKRO)Use our graph to track the performance of AKRO stocks over time.
Akero Therapeutics shares at a glance
|Latest market close||$20.01|
|52-week range||$17.66 - $34.87|
|50-day moving average||$22.10|
|200-day moving average||$24.09|
|Wall St. target price||$47.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.82|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Akero Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Akero Therapeutics price performance over time
|1 week (2022-01-11)||-1.19%|
|1 month (2021-12-17)||-5.26%|
|3 months (2021-10-21)||-4.44%|
|6 months (2021-07-21)||-16.07%|
|1 year (2021-01-21)||-33.05%|
|2 years (2020-01-21)||-12.77%|
|3 years (2019-01-17)||N/A|
|5 years (2017-01-17)||N/A|
Akero Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-23.45%|
|Return on equity TTM||-40.43%|
|Market capitalisation||$776.6 million|
TTM: trailing 12 months
Akero Therapeutics share dividends
We're not expecting Akero Therapeutics to pay a dividend over the next 12 months.
Akero Therapeutics share price volatility
Over the last 12 months, Akero Therapeutics's shares have ranged in value from as little as $17.655 up to $34.87. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akero Therapeutics's is 0.4934. This would suggest that Akero Therapeutics's shares are less volatile than average (for this exchange).
Akero Therapeutics overview
Akero Therapeutics, Inc. , a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. Its lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. The company also conducts a Phase 2a clinical trial, the BALANCED study, to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018.
Akero Therapeutics in the news
Netflix quietly admits streaming competition is eating into growth
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Is Akero Therapeutics, Inc. (AKRO) Outperforming Other Medical Stocks This Year?
Frequently asked questions
More guides on Finder
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.